Hologic, Inc.HOLXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank50
3Y CAGR-21.5%
5Y CAGR-7.3%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-21.5%/yr
vs +78.0%/yr prior
5Y CAGR
-7.3%/yr
Recent deceleration
Acceleration
-99.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.02B | -21.0% |
| 2024 | $1.30B | +16.7% |
| 2023 | $1.11B | -47.4% |
| 2022 | $2.11B | -26.1% |
| 2021 | $2.86B | +91.5% |
| 2020 | $1.49B | +331.8% |
| 2019 | $346.10M | +64.5% |
| 2018 | $210.40M | -88.5% |
| 2017 | $1.83B | +76.9% |
| 2016 | $1.04B | - |